Biomerica (BMRA) Capital Expenditures (QoQ) (2010 - 2023)
Biomerica (BMRA) Capital Expenditures (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -71.43% |
| Feb 28, 2023 | -75.00% |
| Nov 30, 2022 | -29.41% |
| Aug 31, 2022 | 39.04% |
| May 31, 2022 | 70.58% |
| Feb 28, 2022 | 9.67% |
| Nov 30, 2021 | 154.25% |
| Aug 31, 2021 | -82.33% |
| May 31, 2021 | -35.62% |
| Feb 28, 2021 | 105.63% |
| Nov 30, 2020 | -44.48% |
| Aug 31, 2020 | 572.81% |
| May 31, 2020 | -72.51% |
| Feb 29, 2020 | 415.44% |
| Nov 30, 2019 | 91.25% |
| Aug 31, 2019 | -92.30% |
| May 31, 2019 | 41.89% |
| Feb 28, 2019 | 32.46% |
| Nov 30, 2018 | -60.61% |
| Aug 31, 2018 | -32.05% |